Carcinosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
Conditions:   Ovarian Cancer;   Ovarian Carcinoma;   Platinum-resistant Ovarian Cancer;   Fallopian Tube Carcinosarcoma;   Primary Peritoneal Cancer Interventions:   Drug: Pamiparib;   Drug: Surufatinib Sponsors:   Sun Yat-sen University;   HUTCHMED Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials